Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medpace Holdings, Inc.

MEDP ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Large Cap Analyst: HOLD

Last Close

$587.52

▲ +0.75%

Market Cap $16.40B · Vol 51.09K

Key Metrics

P/E Ratio

34.46

FWD: 31.48

Market Cap

$16.40B

Large Cap

Div Yield

N/A

EPS Growth

+15.16%

YoY

RSI (14)

27.02

Momentum

Beta

1.19

vs Market

52W High

$677.90

13.33% below

52W Low

$373.00

57.51% above

Volume

51.09K

Avg 68.92K

P/B

34.63

Price-to-book

ROE

70.23%

Return on equity

Free Float

80.54%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Medpace Holdings, Inc. (MEDP) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MEDP pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.99%

-2.97%

+23.67%

+22.98%

YTD

+4.61%

+18.07%

+110.17%

+206.46%

Financials & Valuation

TTM · Annual

Total Revenue	$2.53B
Net Income	$451.12M
Revenue Growth (YoY)	+17.24%
Gross Margin	28.95%
Operating Margin	21.14%
Net Profit Margin	17.83%
ROE	70.23%
ROA · ROIC	26.61% · 70.23%

P/E Ratio	34.46
Forward P/E (FY1)	31.48
PEG Ratio	1.75
P/S	6.55
P/B	34.63
P/FCF	24.32
EPS Growth	+15.16%
Outstanding Shares	27.91M

Technical Indicators

50-Day SMA	$578.32
200-Day SMA	$520.70
RSI (14)	27.02
Beta	1.19
52-Week High	$677.90
52-Week Low	$373.00

Volume Today	51.09K
Avg Daily Volume (30D)	68.92K
Relative Volume	0.74x
Volatility (10D)	16.28
Volatility (30D)	21.85
Free Float	80.54%

Analyst Consensus

HOLD

Current Price $587.52

Mean Target $568.83

52W Low$373.00 52W High$677.90

Current

Target

$373.00 $677.90

Current Analyst target

-3.18% downside risk · 14 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG0065B7K40

ISINUS58506Q1094

CountryUSA

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateOct 20, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -0.71% ONC BeOne Medicines AG +1.38% 068270.KS Celltrion, Inc. -1.44% ABVX Abivax SA +2.32% ABVX.PA Abivax SA +1.00%

Company Profile

Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.